• Xiangxiang Wu, Zijian Jiang, Jiahui Zheng, Zhuqing Jiao, Tongqiang Liu, Weiqiang Dou, and Haifeng Shi.
• Graduate College, Dalian Medical University, Dalian, China.
• J Neuroimaging. 2022 Sep 1; 32 (5): 930940930-940.

Background And PurposeThis study aimed to investigate the clinical value of intravoxel incoherent motion (IVIM) diffusion-weighted imaging in evaluating the brain microstructure and perfusion changes in end-stage renal disease (ESRD) patients.MethodsThe routine head MRI sequences and IVIM were performed on 40 ESRD patients and 30 healthy subjects. The IVIM was executed with 10 b-values varying from 0 to 1000 seconds/mm2 . All subjects were evaluated on neuropsychological test. Laboratory tests were conducted for ESRD patients.ResultsCompared with the control group, increased slow apparent diffusion coefficient values (ADCslow ) were found in the left frontal lobe, hippocampus, bilateral temporal lobe, and the right occipital lobe (p < .05), and increased fast ADC values (ADCfast ) were found in all regions of interest (all p < .001) in ESRD patients. In ESRD patients, ADCfast in right frontal lobe (p = .041) and insular lobe (p = .045) was negatively correlated with the Montreal Cognitive Assessment score (MoCA), and ADCfast in the right parietal lobe (p = .009) and hippocampus (p = .041) had positive correlation with hemoglobin levels. Using receiver operating characteristics (ROC) analysis, ADCfast in the right frontal lobe, insular lobe, hippocampus, and parietal lobe separately showed fair to good efficacy in differentiating ESRD patients from healthy subjects, with the area under the ROC ranging from .853 to .903.ConclusionsThe microstructure and perfusion of the brain were impaired in ESRD patients. ADCfast of the right frontal lobe, insular lobe, hippocampus, and parietal lobe could be effective biomarker for evaluating cognitive impairment in ESRD patients.© 2022 American Society of Neuroimaging.

15 keywords...

hide…